The Online Investor
Drugs & Pharmaceuticals IPOs image Drugs & Pharmaceuticals IPOs » By The Online Investor Staff, updated Fri., Dec. 14, 7:16 AM
Recent initial public offerings in the Drugs & Pharmaceuticals IPOs category.

Slide #1. Gemphire Therapeutics Inc. Initial Public Offering

Company: Gemphire Therapeutics Inc.
Proposed Symbol: GEMP
Shares Offered: 3,000,000
Price Per Share: $10.00
Over-Allotment: 450,000
Description: Gemphire Therapeutics Inc., a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for the treatment of dyslipidemia, a serious medical condition that increases the risk of life threatening cardiovascular disease, and NAFLD/NASH (nonalcoholic fatty liver disease) today announced the pricing of its initial public offering of 3,000,000 shares of its common stock at a price to the public of $10.00 per share. The shares are expected to begin trading on the NASDAQ Global Market on August 5, 2016 under the ticker symbol "GEMP". The offering is expected to close on August 10, 2016, subject to customary closing conditions. In addition, the underwriters have been granted a 30-day option to purchase up to an additional 450,000 shares of common stock.

IPOs: Gemphire Therapeutics Inc.

List of Drugs & Pharmaceuticals IPOs in this Slideshow: Company Ticker IPO Date Zoetis ZTS Chimerix, Inc. CMRX 4/11/2013 Tetraphase Pharmaceuticals, Inc. TTPH GW Pharmaceuticals plc GWPH PTC Therapeutics, Inc. PTCT Epizyme, Inc. EPZM Conatus Pharmaceuticals Inc. CNAT Aratana Therapeutics, Inc PETX OncoMed Pharmaceuticals, Inc. OMED Agios Pharmaceuticals, Inc. AGIO Onconova Therapeutics, Inc. ONTX Five Prime Therapeutics, Inc. FPRX Evoke Pharma, Inc. EVOK GlycoMimetics, Inc. GLYC Karyopharm Therapeutics Inc. KPTI MacroGenics, Inc MGNX Trevena, Inc. TRVN Xencor XNCR Vital Therapies VTL ADMA Biologics ADMA Aerie Pharmaceuticals AERI Cara Therapeutics CARA Kindred Bio KIN Flexion Therapeutics, Inc. FLXN Achaogen AKAO Dicerna Pharmaceuticals, Inc. DRNA Ultragenyx Pharmaceutical Inc. RARE Intra-Cellular Therapies ITCI uniQure B.V. QURE Revance Therapeutics RVNC Eagle Pharmaceuticals EGRX Concert Pharmaceuticals CNCE Akebia Therapeutics AKBA Recro Pharma, Inc. REPH Aquinox Pharmaceuticals, Inc. AQXP Phibro Animal Health Corporation PAHC Galmed Pharmaceuticals GLMD Agile Therapeutics, Inc. AGRX MediWound Ltd MDWD SCYNEXIS SCYX Phibro Animal Health Corporation PAHC Adamas Pharmaceuticals, Inc. ADMS Aldeyra Therapeutics ALDX Pfenex Inc PFNX 7/24/2014 Radius Health, Inc. RDUS Zafgen, Inc. ZFGN Lantheus Holdings, Inc. LNTH Amphastar Pharmaceuticals, Inc. AMPH Karyopharm Therapeutics Inc. KPTI Affimed AFMD Minerva Neurosciences, Inc. NERV SAGE Therapeutics, Inc SAGE Auris Medical Holding AG EARS Immune Design IMDZ 7/24/2014 Ocular Therapeutix OCUL ContraFect Corporation CFRX Bio Blast Pharma Ltd. ORPN Catalent, Inc. CTLT Marinus Pharmaceuticals, Inc. MRNS Loxo Oncology, Inc. LOXO Foamix Pharmaceuticals Ltd. FOMX ProQR Therapeutics PRQR Calithera Biosciences, Inc. CALA Dermira DERM Xenon Pharmaceuticals Inc. XENE Bellicum Pharmaceuticals, Inc. BLCM Ascendis Pharma A/S ASND Flex Pharma, Inc. FLKS Bellerophon Therapeutics BLPH Blueprint Medicines Corporation BPMC aTyr Pharma, Inc. LIFE Xbiotech XBIT KemPharm, Inc. KMPH 4/16/2015 Viking Therapeutics, Inc. VKTX Collegium Pharmaceutical, Inc. COLL Axovant Sciences Ltd. AXON Ritter Pharmaceuticals, Inc. RTTR Catabasis Pharmaceuticals CATB Seres Therapeutics, Inc. MCRB Neos Therapeutics, Inc. NEOS vTv Therapeutics Inc. VTVT Intec Pharma Ltd. NTEC Zynerba Pharmaceuticals, Inc. ZYNE Aimmune Therapeutics, Inc. AIMT Nabriva Therapeutics AG NBRV CytomX Therapeutics, Inc. CTMX MyoKardia, Inc. MYOK Kitov Pharmaceuticals Holdings Ltd. KTOV BeiGene, Ltd. BGNE Proteostasis Therapeutics, Inc. PTI Syndax Pharmaceuticals, Inc. SNDX Corvus Pharmaceuticals, Inc. CRVS Aeglea BioTherapeutics, Inc. AGLE Spring Bank Pharmaceuticals, Inc. SBPH Merus B.V. MRUS Reata Pharmaceuticals, Inc. RETA Clearside Biomedical, Inc. CLSD Selecta Biosciences, Inc. SELB Kadmon Holdings, Inc. KDMN Gemphire Therapeutics Inc. GEMP

Drugs & Pharmaceuticals IPOs Page |

Copyright © 1998 - 2018, All Rights Reserved Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.